Navis Clinical Laboratories Joins Nashville Area Health Services Community With Grand Opening of New Headquarters

Navis Clinical Laboratories (navisclinical.com), a leading provider of laboratory services that is making groundbreaking strides in healthcare solutions for substance use disorder and other disease states, celebrated its official grand opening with a ribbon-cutting ceremony at its new corporate headquarters located in the Greater Nashville area city of Franklin, Tenn.

Focused on innovative, cutting-edge research and development, Navis provides laboratory drug testing solutions and molecular and clinical blood testing for healthcare providers to aid in the diagnosis, treatment, management and prevention of substance use disorder, mental health conditions, chronic pain, and common comorbid acute and chronic diseases, including HIV/AIDS, hepatitis, sexually transmitted infections (STIs), urinary tract infections (UTIs), respiratory infections and antibiotic resistant infections.

President and CEO Richard Stripp, Ph.D., who was joined by Navis leadership, employees, friends and family, shared his excitement about Navis’ future. “We’re delighted to be in Nashville, the health services capital of the U.S., and to have the opportunity to bring business and jobs to the area. We have a very aggressive growth strategy, and this is just the beginning for us. We have a national footprint serving clients nationwide, and this move will help facilitate our evolution into a one-stop shop for our clients and allow us to deliver services to patients who really need our help.”

Lori Odom, Senior Vice President of Economic Development, Nashville Area Chamber of Commerce, opened the ceremony with a warm welcome to Navis Clinical Laboratories, which joins the area’s robust and diverse health care community of more than 500 health care companies, making it the largest industry in the region. “Nashville is known as Music City, but it is also Healthcare City. Our mission is to create economic prosperity by facilitating leadership and partnership with companies, and Navis is a great example of what that can accomplish,” said Odom.

“At Navis, we understand that behind everything we do is a human being whose life is directly impacted by the services we provide,” said Dr. Stripp. “Many patients we serve have complex health conditions. Navigating the healthcare system to find care that treats the whole patient rather than just a single illness is often a challenge. We advocate for those patients by developing solutions that empower healthcare providers to provide exceptional care, improve outcomes and save lives.”

Navis launched in February of this year and currently owns three state-of-the-art laboratories located in New York, Washington and Massachusetts, allowing it to provide services nationally to healthcare practices. Dr. Stripp originally founded the New York laboratory location as American Forensic Toxicology Services.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The ArthroFree system is the first FDA-cleared wireless camera for arthroscopy and general endoscopy, both areas of minimally invasive surgery. The system is designed to help surgeons work with aximum dexterity and focus.
The project, which was led by the University of Southern California, included large increases in representation among men of African, Hispanic and Asian ancestries, that were contributed in part by an ongoing collaboration between the U.S. Department of Veterans Affairs and DOE reports Argonne.
This innovative software turns smartphones into medical-grade stethoscopes, allowing people to capture, analyze, and share critical heart health data with medical personnel from the comfort of any location notes Sparrow BioAcoustics.
"Taewoong Medical becoming an Olympus group company is also a major milestone in our global growth strategy," said Henry Shin, CEO of STARmed. "We look forward to our products being made available to more patients through Olympus' global distribution network."
The company reports they have successfully met the six-month primary endpoint for the first-ever female patient implanted with the UroActive™ System, the first smart automated artificial urinary sphincter (AUS) to treat SUI.

By using this website you agree to accept Medical Device News Magazine Privacy Policy